Company Name | Galena Biopharma |
---|---|
Website | https://www.marketscreener.com |
Snippet | GALENA BIOPHARMA INC. --.--%. SELLAS Life Sciences Group, Inc. is a biopharmaceutical company that is focused on developing cancer immunotherapeutics for a range of cancer indications. The Company’s product candidates include galinpepimut-S and nelipepimut-S. Its lead product candidate, galinpepimut-S is a cancer immunotherapeutic agent ... |
Fate | Acquired by SELLAS Life Sciences Group |
Defunct | December 29, 2017 (2017-12-29) |
Founded | 2006 |
Revenue | $7.4 million (2014) |
Website | www.sellaslifesciences.com |
Formerly | RXi Pharmaceuticals |
Industry | Biotechnology |
Products | NeuVax |
Key people | Mark Schwartz, CEO |
Former type | Public (NASDAQ: GALE) |
Headquarters | San Ramon, California, United States |
Number of employees | 60 (March 2014) |
Galena Biopharma is part of the United States company list
Galena Biopharma is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us